建模ANKRD26 5'-UTR突变相关的血小板缺血症
Liang Zheng1,2, Zhijian Wu1,3, Noritaka Yada1
1Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS 66126, USA.
Disease models & mechanisms
|April 2, 2025
概括
过度表达ANKRD26 (ankyrin重复域含有蛋白 26) 会导致血栓缺血和血栓形成. 带有ankrd26突变的斑马鱼表现出遗传性血小板缺血2 (THC2) 特性,包括血小板数量低和凝血增加. 这表明ANKRD26在血液疾病中起着关键作用.
科学领域:
- 血液学 血液学 血液学
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 安基林重复域含蛋白26 (ANKRD26) 的5'-未翻译区域 (5'-UTR) 的突变与遗传性血小板缺血2 (THC2) 有关.
- 这些突变的确切作用和驱动THC2的机制仍然不清楚.
研究的目的:
- 在斑马鱼模型中研究ankrd26 5'-UTR突变的功能后果.
- 阐明ANKRD26在血小板缺血,血栓形成和潜在的血液性恶性瘤中的作用.
主要方法:
- 生成的斑马鱼在ankrd26 5'-UTR (ank26ku6) 中具有特定的2核酸删除 (Δ2).
- 分析了斑马鱼幼虫和成人的ankrd26mRNA和蛋白质表达水平.
- 在 ank26ku6 鱼中评估了血小板计数,粘附和聚合.
- 进行了血栓细胞的蛋白质基因分析.
- 检查了长期结果,包括骨髓质疏松症候群的发展.
- 在患有免疫血栓性血栓性缺血性紫外线的人类患者中比较ANKRD26蛋白水平.
主要成果:
- 带有ankrd26 Δ2删除的斑马鱼表现出ankrd26表达的增加,并发展出自发的血小板缺血症.
- 来自突变鱼类的血小板显示了增强的粘附和聚合.
- 蛋白质组学揭示了在突变血栓细胞中对宁林1的升高调节.
- 突变鱼在生命的晚年发展出骨髓质疏松综合征.
- 在患有免疫血栓性血栓塞性紫外线的患者的血小板和血中观察到ANKRD26蛋白的升高.
结论:
- ANKRD26的过度表达,无论是遗传的还是获得的,都会导致血小板缺血和血栓形成.
- 这些发现确定了ANKRD26失调和血液恶性瘤之间的联系.
- 这项研究为了解THC2病原和ANKRD26在血液疾病中的更广泛作用提供了一个模型.
相关概念视频
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:32RNA Splicing
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
02:18Alternative RNA Splicing
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...